Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Total 13F shares
-
65,888,228
-
Share change
-
-5,790,849
-
Total reported value
-
$247,927,417
-
Put/Call ratio
-
241%
-
Price per share
-
$3.76
-
Number of holders
-
131
-
Value change
-
-$30,654,965
-
Number of buys
-
68
-
Number of sells
-
90
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q1 2025
As of 31 Mar 2025 Olema Pharmaceuticals, Inc. - Common Stock (OLMA) had 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,888,228 shares of stock of the company.
Largest 10 holders included Bain Capital Life Sciences Investors, LLC, Paradigm Biocapital Advisors LP, BVF INC/IL, BlackRock, Inc., Deep Track Capital, LP, Logos Global Management LP, FRANKLIN RESOURCES INC, MPM BIOIMPACT LLC, VANGUARD GROUP INC, and LIGHTSPEED MANAGEMENT COMPANY, L.L.C..
This table shows 132 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.